PharmaEssentia to Present Preclinical Pipeline Data at SITC Meeting
The company says two posters will highlight preclinical data for PEC 2001 and 3001, including a myeloid checkpoint inhibitor.
The company says two posters will highlight preclinical data for PEC 2001 and 3001, including a myeloid checkpoint inhibitor.